(800) 603-4795 ext. 729
This form is intended for US medical professionals requesting information on ASCOR® Ascorbic Acid Injection (Vitamin C Injection) only. If you are a US healthcare professional and have a medical inquiry, please complete this form and submit to receive a response from McGuff Pharmaceuticals Scientific Liaison team. McGuff Pharmaceuticals Scientific Liaison team may be reached by calling 1-800-603-4795 ext. 729. If you have a non-medical inquiry please use our Other Requests form.
ASCOR® is vitamin C indicated for the short term (up to 1 week) treatment of
scurvy in adult and pediatric patients age 5 months and older for whom oral
administration is not possible, insufficient or contraindicated.
Limitations of Use:
ASCOR® is not indicated for treatment of vitamin C deficiency that is not associated with signs and symptoms of scurvy.
Administration site reactions include pain and swelling.
ASCOR® should not be rapidly administered. Rapid intravenous administration (>250 mg/minute) of ASCOR® may cause temporary faintness or nausea, lethargy, flushing, dizziness, and headache.
Acute and chronic oxalate nephropathy have occurred with prolonged administration of high doses of ascorbic acid. ASCOR® is not indicated for prolonged administration. The maximum recommended duration is one week.
In patients with glucose-6-phosphate dehydrogenase deficiency severe hemolysis has occurred.
Ascorbic acid may interfere with laboratory tests based on oxidation-reduction reactions, including blood and urine glucose testing, nitrite and bilirubin levels, and leucocyte count testing. If possible, laboratory tests based on oxidation-reduction reactions should be delayed until 24 hours after infusion of ASCOR®.
Please see accompanying Full Prescribing Information for ASCOR®.
The information contained in this section of the site is intended for U.S. healthcare professionals only.